Showing 1 - 10 of 38
Oped, Sally Tyler, Published on 13/03/2026
» On the day I am writing this editorial, I was meant to be travelling to Bangkok for one of my periodic visits to a city I have grown to love. I am always keen to shave off a few hours from a long-haul flight, which means the shortest flight path from my home in Washington, DC, would take me through Abu Dhabi, but my flight was cancelled like thousands of others due to the ongoing conflict in the Mideast. My inconvenience is nothing compared to the destruction endured by those on the ground, but it illustrates the expanding global impact of the US/Israel/Iran War.
Oped, Carla Norrlöf, Published on 06/03/2026
» As the conflict with Iran reshapes global security assumptions and energy markets, the debate in the United States has focused largely on why President Donald Trump chose war in the first place. Was it domestic politics, a desire to project strength, a miscalculation, or something else?
News, Evgeny Tomikhin, Published on 21/02/2026
» Difficult negotiations on how to settle the conflict in and around Ukraine are continuing in Geneva, Switzerland, and Abu Dhabi, United Arab Emirates. While the conditions of a long-term settlement are under discussion, it is timely to revisit a question that remains central for the international community: why, despite repeated declarations of commitment to peace, has the conflict yet to be resolved?
Oped, Mohammad Abu Hajar, Published on 18/07/2025
» In Syria, the caged bird raps. On my first night imprisoned, I began to write:
Oped, John J Metzler, Published on 22/05/2025
» With the showmanship of a Cecil B De Mille saga, President Donald Trump's state visit to three Arab kingdoms was uniquely paired with pomp and joint business incentives that focused on transforming the narrative from conflict to commerce and cooperation. The visits were set to the spectacular backdrop of casts of thousands, Arabian stallions, and camel cohorts marking the fanfare of the president's four-day trip to the region.
Oped, Muhammad Radzi Abu Hassan, Published on 29/04/2025
» The successful collaboration between the health ministries of Malaysia and Thailand, industry partners in Egypt and Malaysia, and the Drugs for Neglected Diseases initiative (DNDi) to bring a new hepatitis C antiviral drug -- ravidasvir -- to market in 2022 was an important milestone. For years, a 12-week course of treatment using sofosbuvir cost between $70,000 (2.34 million baht) and $80,000, putting it out of reach for many in the Global South. But ravidasvir -- a safe and effective alternative when combined with sofosbuvir -- costs far less, averaging less than $500 per course.
Oped, John J. Metzler, Published on 24/04/2025
» The Four Horsemen of the Apocalypse are stalking Sudan: brutal civil conflict, widespread devastation, humanitarian disasters, and the displacement of millions of refugees. Now add the Fifth Horseman, the darkness of global indifference.
News, Slavoj Žižek, Published on 23/12/2024
» The downfall of Bashar al-Assad's regime in Syria surprised even the opposition, led by Abu Mohammad al-Jolani's Hayat Tahrir al-Sham, offering fertile ground for conspiracy theories.
Oped, Kantathi Suphamongkhon, Published on 20/12/2024
» I often wondered how much of our lives are predetermined by forces beyond our comprehension.